Easy ways to get the answers you need.
+91 79 65123395
+91 79 26463395
Manus Aktteva Biopharma LLP, a global supplier of Labetalol hydrochloride, 32780-64-6 offers for your requirements of RND / Development quantities or commercials, based on status of the product. We can also offer its intermediates with supportive technical package required for evaluation.
Product Reference ID:
labrocol, Labetalol hydrochloride
2-hydroxy-5-(1-hydroxy-2-((1-methyl-3-phenylpropyl)amino)ethyl)-benzamidmo;5-(1-hydroxy-2-((1-methyl-3-phenylpropyl)amino)ethyl)salicylamidehydrochlori;5-(1-hydroxy-2-((1-methyl-3-phenylpropyl)amino)ethyl)-salicylamidhydroch;ah5158a;amipress;ipolab;labelol;labrocol, Labetalol hydrochloride
Available on request
Export worthy packing
Material Safety Data Sheet
Available on request
The list of intermediates for Labetalol hydrochloride will be updated soon.
If you can not locate your required intermediate for Labetalol hydrochloride on this page, you may send us a sourcing request for the specific Labetalol hydrochloride intermediate you are looking for along with its Cas No., and the Intermediate name and we shall come back to you promptly with more details. Please click here to send an email.
Please note that Manus Aktteva Biopharma LLP website is a dynamic one with the new contents revised/updated regularly. Hence it would be most beneficial for you to visit the website again and again till you gain!
Our customers expect a prompt response on both the quotes and delivery of the product. As a general rule, we respond to new enquiry within 48 hours after the initial screening of product availability and supply ability if the material is not in stock. If any project is initiated already, we provide each customer with a report as to when we can offer you the requested product along with the actual status of the synthesis of the project. This facilitates real-time feedback to our customers.
We listen carefully to our customer's concerns and needs and address each of their requirements promptly and effectively.
- Products protected by valid patents are not offered for sale in countries where the sale of such products constitutes a patent infringement and its liability is at buyer's risk.
- Products currently covered by valid US Patents are offered for R&D use in accordance with 35 USC 271 +A13(1)
Are you looking for Labetalol hydrochloride with documentation like CEP / COS, PMDA - JAPAN, DMF - CANADA, TGA - AUSTRALIA, DMF (CLOSED PART), MHRA - UK, DMF - KOREA, AIFA - ITALY, TDP, MEDSAFE - NEW ZEALAND, HEALTH CANADA, JAPAN - AFM, DMF - CTD, DCGI, ICH? Please
to send us sourcing request.